78% of FDA-approved NDAs and BLAs in 2020 included an RWE study.
Aetion conducted a systematic review of FDA approval documents to understand the role RWE plays in providing evidence of safety and/or effectiveness in regulatory decisions. This year’s eBook will guide you through when, where, and how RWE supported approvals in 2020.
